As I understand it, the company have been focussing on growth in the US, and will more than likely turn that focus to the rest of the world once their objectives have been met in the US. FDA approval, and the ability to sell in the US, is a massive incentive for the rest of the world to take notice of this company and the products they have. Great update, and for my money, the CR price will be a distant memory in the not too distant future.
As I understand it, the company have been focussing on growth in...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.020(8.00%) |
Mkt cap ! $52.62M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 22.0¢ | $204.6K | 871.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 42500 | 1 |
View Market Depth
| Last trade - 15.59pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
23.0¢ |
Change
-0.020 ( 8.00 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 24.5¢ | 22.0¢ | 251353 | ||
| Last updated 15.41pm 17/05/2024 ? | |||||
| EYE (ASX) Chart |